Hopium S.A [ALHPI] vs Hermès International [RMS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Hopium S.A wins in 5 metrics, Hermès International wins in 10 metrics, with 0 ties. Hermès International appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricHopium S.AHermès InternationalBetter
P/E Ratio (TTM)0.0050.62Hopium S.A
Price-to-Book RatioN/A13.65N/A
Debt-to-Equity Ratio-0.3912.23Hopium S.A
EV/EBITDA-1.6932.30Hopium S.A
Profit Margin (TTM)-22,576.11%28.54%Hermès International
Operating Margin (TTM)-21,773.16%42.28%Hermès International
EBITDA Margin (TTM)N/A42.28%N/A
Return on Equity29.59%28.55%Hopium S.A
Return on Assets (TTM)-131.82%19.09%Hermès International
Free Cash Flow (TTM)$-8.43M$5.14BHermès International
Dividend YieldN/A0.70%N/A
1-Year Return-50.00%-0.80%Hermès International
Price-to-Sales Ratio (TTM)48.9614.43Hermès International
Enterprise Value$13.02M$218.28BHermès International
EV/Revenue Ratio629.8113.90Hermès International
Revenue per Share (TTM)$0$150Hermès International
Earnings per Share (Diluted)$-0.81$42.69Hermès International
Beta (Stock Volatility)-0.580.82Hopium S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Hopium S.A vs Hermès International Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hopium S.A4.65%0.00%0.00%-50.00%-50.00%-50.00%
Hermès International0.33%1.54%3.47%-11.88%-0.94%-8.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hopium S.A-50.00%-99.93%-99.82%-99.82%-99.82%-99.82%
Hermès International-0.80%61.76%164.97%532.57%1,095.25%3,340.70%

News Based Sentiment: Hopium S.A vs Hermès International

Hopium S.A

News sentiment data is not available for Hopium S.A at this time.

Hermès International

News based Sentiment: POSITIVE

October presented a generally positive picture for Hermès, with consistent revenue growth forecasts, rising stock prices, and increased analyst price targets. While the luxury sector faces broader pressures, Hermès demonstrates resilience and continued investor confidence, justifying a 'positive' sentiment and a relatively high importance score.

View Hermès International News Sentiment Analysis

Performance & Financial Health Analysis: Hopium S.A vs Hermès International

MetricALHPIRMS
Market Information
Market Cap i€999,973€233.90B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i3,208,25952,138
90 Day Avg. Volume i4,424,57252,793
Last Close€0.01€2,115.00
52 Week Range€0.01 - €3.20€1,957.00 - €2,957.00
% from 52W High-99.72%-28.47%
All-Time High€42.00 (Jun 28, 2021)€2,957.00 (Feb 10, 2025)
% from All-Time High-99.98%-28.47%
Growth Metrics
Quarterly Revenue GrowthN/A0.07%
Quarterly Earnings GrowthN/A-0.05%
Financial Health
Profit Margin (TTM) i-225.76%0.29%
Operating Margin (TTM) i-217.73%0.42%
Return on Equity (TTM) i0.30%0.29%
Debt to Equity (MRQ) i-0.3912.23
Cash & Liquidity
Book Value per Share (MRQ)€-3.65€158.36
Cash per Share (MRQ)€0.11€98.45
Operating Cash Flow (TTM) i€-8,427,000€5.22B
Levered Free Cash Flow (TTM) i€-7,215,765€3.74B
Dividends
Last 12-Month Dividend Yield iN/A0.70%
Last 12-Month Dividend iN/A€16.00

Valuation & Enterprise Metrics Analysis: Hopium S.A vs Hermès International

MetricALHPIRMS
Price Ratios
P/E Ratio (TTM) i0.0050.62
Forward P/E iN/A45.32
PEG Ratio iN/AN/A
Price to Sales (TTM) i48.9614.43
Price to Book (MRQ) iN/A13.65
Market Capitalization
Market Capitalization i€999,973€233.90B
Enterprise Value i€13.02M€218.28B
Enterprise Value Metrics
Enterprise to Revenue i629.8113.90
Enterprise to EBITDA i-1.6932.30
Risk & Other Metrics
Beta i-0.580.82
Book Value per Share (MRQ) i€-3.65€158.36

Financial Statements Comparison: Hopium S.A vs Hermès International

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ALHPIRMS
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ALHPIRMS
Cash & Equivalents i€1.05M€10.32B
Total Current Assets i€2.56M€14.37B
Total Current Liabilities i€24.68M€3.19B
Long-Term Debt i€10.99M€1.73B
Total Shareholders Equity i€-35.56M€16.62B
Retained Earnings i€-10.52M€2.25B
Property, Plant & Equipment i€1.14M€4.52B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ALHPIRMS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALHPIRMS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,208,25952,138
Average Daily Volume (90 Day) i4,424,57252,793
Shares Outstanding i9.74M104.84M
Float Shares i9.73M34.31M
% Held by Insiders i0.01%0.67%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Hopium S.A vs Hermès International

MetricALHPIRMS
Last 12-Month Dividend iN/A€16.00
Last 12-Month Dividend Yield iN/A0.70%
3-Year Avg Annual Dividend iN/A€14.67
3-Year Avg Dividend Yield iN/A0.33%
3-Year Total Dividends iN/A€44.00
Ex-Dividend DateN/AMay 05, 2025